AI assistant
BioAtla, Inc. — Director's Dealing 2022
Aug 15, 2022
34681_dirs_2022-08-15_798628b3-e234-407d-8bd0-fafc92b75eec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2022-08-12
Reporting Person: SHORT JAY M PHD (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-12 | Common Stock | P | 26350 | $7.8406 | Acquired | 1396556 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 793547 | Indirect |
| Common Stock | 258727 | Indirect |
| Common Stock | 258727 | Indirect |
| Common Stock | 302324 | Indirect |
| Common Stock | 50 | Indirect |
Footnotes
F1: The range of prices for the shares of Common Stock is from $7.67 to $8.00. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F2: The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein.